Curbstone Financial Management Corp Pfizer Inc Transaction History

Curbstone Financial Management Corp

$458 Million
Q3 2024

A detailed history of Curbstone Financial Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, Curbstone Financial Management Corp holds 57,959 shares of PFE stock, worth $1.59 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

57,959

Previous 61,773 6.17%

Holding current value

$1.59 Million

Previous $1.73 Million 2.95%

% of portfolio

0.37%

Previous 0.38%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$27.7 - $31.39 $105,647 - $119,721	-3,814 Reduced 6.17%	57,959 $1.68 Million
Q2 2024 Jul 03, 2024	BUY	$25.26 - $29.6 $1,263 - $1,480	50 Added 0.08%	61,773 $1.73 Million
Q1 2024 Apr 09, 2024	BUY	$25.89 - $29.73 $37,540 - $43,108	1,450 Added 2.41%	61,723 $1.71 Million
Q4 2023 Jan 08, 2024	BUY	$26.13 - $33.94 $13,065 - $16,970	500 Added 0.84%	60,273 $1.74 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $6,418 - $7,502	-200 Reduced 0.33%	59,773 $1.98 Million
Q2 2023 Jul 05, 2023	SELL	$36.12 - $41.79 $7,946 - $9,193	-220 Reduced 0.37%	59,973 $2.2 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $6,223 - $8,102	158 Added 0.26%	60,193 $2.46 Million
Q4 2022 Jan 19, 2023	BUY	$41.75 - $54.5 $7,097 - $9,265	170 Added 0.28%	60,035 $3.08 Million
Q3 2022 Oct 05, 2022	SELL	$43.76 - $53.42 $3,763 - $4,594	-86 Reduced 0.14%	59,865 $2.62 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $276,853 - $328,261	-5,950 Reduced 9.03%	59,951 $3.14 Million
Q1 2022 Apr 18, 2022	BUY	$45.75 - $56.69 $9,150 - $11,338	200 Added 0.3%	65,901 $3.41 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $124,042 - $183,872	-3,002 Reduced 4.37%	65,701 $3.88 Million
Q3 2021 Oct 06, 2021	BUY	$39.25 - $50.42 $47,728 - $61,310	1,216 Added 1.8%	68,703 $2.96 Million
Q2 2021 Jul 09, 2021	BUY	$35.91 - $40.68 $28,727 - $32,544	800 Added 1.2%	67,487 $2.64 Million
Q1 2021 Apr 05, 2021	SELL	$33.49 - $37.77 $26,792 - $30,216	-800 Reduced 1.19%	66,687 $2.42 Million
Q4 2020 Jan 14, 2021	BUY	$33.47 - $42.56 $114,601 - $145,725	3,424 Added 5.34%	67,487 $2.48 Million
Q3 2020 Oct 02, 2020	BUY	$31.75 - $37.25 $26,987 - $31,662	850 Added 1.34%	64,063 $2.35 Million
Q2 2020 Jul 10, 2020	BUY	$30.12 - $36.54 $7,530 - $9,135	250 Added 0.4%	63,213 $2.07 Million
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $44,599 - $63,722	-1,650 Reduced 2.55%	62,963 $2.06 Million
Q4 2019 Jan 10, 2020	BUY	$32.92 - $37.36 $27,982 - $31,756	850 Added 1.33%	64,613 $2.53 Million
Q3 2019 Oct 18, 2019	BUY	$32.49 - $42.13 $12,671 - $16,430	390 Added 0.62%	63,763 $2.29 Million
Q2 2019 Jul 09, 2019	SELL	$36.98 - $41.52 $26,218 - $29,437	-709 Reduced 1.11%	63,373 $2.75 Million
Q1 2019 Apr 10, 2019	BUY	$37.5 - $41.2 $149,437 - $164,182	3,985 Added 6.63%	64,082 $2.72 Million
Q4 2018 Jan 09, 2019	SELL	$38.47 - $43.86 $5,385 - $6,140	-140 Reduced 0.23%	60,097 $2.62 Million
Q4 2018 Jan 08, 2019	BUY	$38.47 - $43.86 $6,309 - $7,193	164 Added 0.27%	60,237 $2.19 Million
Q3 2018 Oct 10, 2018	SELL	$34.47 - $41.81 $5,653 - $6,856	-164 Reduced 0.27%	60,073 $2.65 Million
Q2 2018 Jul 06, 2018	BUY	$32.98 - $35.16 $34,629 - $36,918	1,050 Added 1.77%	60,237 $2.19 Million
Q1 2018 Apr 10, 2018	BUY	$31.91 - $37.02 $943,291 - $1.09 Million	29,561 Added 99.78%	59,187 $2.1 Million
Q4 2017 Jan 08, 2018	SELL	$33.26 - $35.29 $957,123 - $1.02 Million	-28,777 Reduced 49.27%	29,626 $1.07 Million
Q3 2017 Oct 03, 2017	BUY	$31.0 - $34.15 $1.81 Million - $1.99 Million	58,403	58,403 $2.09 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.

Account

Curbstone Financial Management Corp Pfizer Inc Transaction History